{"id":"W4379337518","doi":"10.1200/jco.2023.41.16_suppl.2022","title":"Ombipepimut dosing emulsion (ODE) + bevacizumab (bev) vs bev alone in patients (pts) with recurrent or progressive glioblastoma (rGBM).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Clinical endpoint; Bevacizumab; Internal medicine; Debulking; Temozolomide; Concordance; Oncology; Nuclear medicine; Surgery; Clinical trial; Cancer; Chemotherapy; Ovarian cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007222253,0.0004746502,0.000940947,0.0002135662,0.0001410507,0.0004622432,0.0002687016,0.0004928774,0.003621389],"category_scores_gemma":[0.000981502,0.0002020737,0.0007942534,0.000225024,0.0002566188,0.0005041048,0.0002865012,0.001276536,0.0004660813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006429284,"about_ca_system_score_gemma":0.000676356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006703121,"about_ca_topic_score_gemma":0.002257046,"domain_scores_codex":[0.9998118,0.0000840861,0.00001419677,0.00003255542,0.00001916357,0.0000381844],"domain_scores_gemma":[0.9997041,0.00008753165,0.00007660428,0.00001268797,0.00001321457,0.0001058034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8605252,0.0113393,0.005353473,0.0006865465,0.001096666,0.000128779,0.0001133607,0.001750752,0.005636788,0.0002612184,0.002524745,0.110583],"study_design_scores_gemma":[0.3273473,0.640315,0.02134085,0.000100053,0.001126931,0.0002316306,0.00009894019,0.002561013,0.002236275,0.0005739425,0.004041754,0.00002637367],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952023,0.001749037,0.0001986582,0.0002599471,0.0001359569,0.000588223,0.0003496304,0.00002381607,0.001492372],"genre_scores_gemma":[0.9960893,0.0009343285,0.0003517678,0.0003603506,0.00008797132,0.0005694157,0.0003783525,0.000006531319,0.001221858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003621389,"threshold_uncertainty_score":0.01211476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03366958217915085,"score_gpt":0.3902121164525658,"score_spread":0.3565425342734149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}